Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%.
Source link
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
![Weight-Loss Drug Wegovy Cuts Heart Risk in New Study](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Weight-Loss-Drug-Wegovy-Cuts-Heart-Risk-in-New-Study-1200x640.jpeg)
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%.
Source link